Ari Bousbib
CIK 1184180 · See Remarks · last filed 2026-07-31
Ari Bousbib is a corporate insider who has filed 90 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for IQV, was dated Jul 31, 2026. Across all open-market trades the lifetime net is −$304.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $594.7M across reported positions. 30 SEC filings were submitted jointly with UNITED TECHNOLOGIES CORP /DE/.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IQV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE FINANCIAL PLAZA
HARTFORD, CT 06101
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IQV | See Remarks | 1,482,361 | $262.37 | $388.92M | -$236.10M | 39 | 2026-07-31 |
| HD | Director | 10,000 | $349.96 | $3.50M | $266.4K | 20 | 2026-05-26 |
| Q | See Remarks | 1,580,141 | $110.42 | $174.48M | -$22.09M | 6 | 2017-11-03 |
| IMS Health Holdings, Inc. (IMS) Delisted | See Remarks | 1,917,133 | — | — | $0 | 5 | 2016-10-03 |
| RTX | Pres., Commercial & UTC EVP | 144,755 | $192.19 | $27.82M | -$46.22M | 15 | 2010-03-26 |
| BBY | Director | — | $99.38 | — | $0 | 1 | 2007-04-12 |
Recent Filings
90 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-31 | IQV | Mixed | — | -$26.09M | EDGAR |
| 2026-07-29 | IQV | Notice (144) | −106,279 | -$26.09M | EDGAR |
| 2026-05-26 | HD | Grant (A) | — | $0 | EDGAR |
| 2026-02-11 | IQV | Grant (A) | — | $0 | EDGAR |
| 2026-02-10 | IQV | Mixed | +28,778 | -$5.32M | EDGAR |
| 2025-12-19 | IQV | Mixed | — | -$8.13M | EDGAR |
| 2025-12-18 | IQV | Notice (144) | −36,564 | -$8.13M | EDGAR |
| 2025-10-31 | IQV | Mixed | — | -$12.46M | EDGAR |
| 2025-10-29 | IQV | Notice (144) | −56,557 | -$12.46M | EDGAR |
| 2025-05-27 | HD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.